NanoString Finds a Buyer, Slide Tags Enter in Early Access as Curio Trekker, Cellares Unveils Cell Therapy Manufacturing Platform

This week, the GEN editors discuss business news from NanoString, Curio, and Cellares.

Featuring Alex Philippidis (Senior Business Editor), Uduak Thomas (Senior Editor), Jonathan Grinstein, PhD, (Senior Editor), and moderated by Corinna Singleman, PhD, (Managing Editor).

Listed below are key references to the GEN stories, media, and other items discussed in this episode of Touching Base:

The State of Omics 2024 Registration
GEN Summit

NanoString Agrees to be Acquired by Investment Firm for $220M
By GEN, March 11, 2024.

Curio Begins Testing Commercial Spatial Barcoding Technology for Single Cell Sequencing
By GEN, March 12, 2024

Cellares Unveils Clinically-Compliant Cell Therapy Manufacturing Platform
By Jonathan D. Grinstein, PhD, GEN, March 12, 2024